Apolipoprotein B-48: comparison of fasting concentrations measured in normolipidaemic individuals using SDS-PAGE, immunoblotting and ELISA

Atherosclerosis
K G Jackson, C M Williams

Abstract

Raised levels of chylomicrons and chylomicron remnants, which circulate following a meal, have been implicated in the development of atherosclerosis. Apolipoprotein (apo) B-48 is exclusively associated with chylomicron particles and provides a specific direct measurement of the number of intestinally derived lipoproteins in the circulation. The quantification of apo B-48 in biological samples is difficult due to the very low concentration in plasma, structural similarity to the N-terminal 48% of apo B-100 and lack of an appropriate standard for apo B-48. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), followed by coomassie blue staining, has been used for many years to measure apo B-48 levels in triacylglycerol (TAG)-rich lipoprotein samples. The raising of antiserum to apo B-48 has led to development of more sensitive and specific methods including immunoblotting and enzyme-linked immunosorbant assays (ELISAs). This has enabled direct measurement of apo B-48 in plasma without the need for separation into TAG-rich lipoproteins. A high degree of variability was observed in the apo B-48 concentrations reported in the literature both within and between the SDS-PAGE, immunoblotting and ELISA methods.

References

Jan 1, 1986·Methods in Enzymology·D A Hardman, J P Kane
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J P KaneH E Paulus
Mar 1, 1993·The Journal of Clinical Investigation·F KarpeA Hamsten
Jan 1, 1996·Methods in Enzymology·F KarpeG Steiner
Jan 1, 1996·Methods in Enzymology·D M Lee
Mar 1, 1997·The Proceedings of the Nutrition Society·S G IsherwoodB J Gould
Oct 16, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J S CohnJ Davignon
Jul 20, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·B SavianaJ L Guéant
Feb 13, 2001·European Journal of Clinical Investigation·C A Dane-StewartT G Redgrave
Oct 17, 2001·Current Atherosclerosis Reports·E J Parks
Feb 9, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Björn LundahlFredrik Karpe
Jun 22, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J A LovegroveC M Williams
Jul 30, 2002·The American Journal of Clinical Nutrition·Charles CouillardJean-Pierre Després
Dec 17, 2002·Atherosclerosis·K D Renuka R SilvaChristine M Williams
Feb 4, 2003·Journal of Lipid Research·Yongsoon Park, William S Harris
Apr 3, 2003·Journal of Lipid Research·Naohiko SakaiYuji Matsuzawa

❮ Previous
Next ❯

Citations

Sep 29, 2011·Journal of Atherosclerosis and Thrombosis·Daisaku MasudaShizuya Yamashita
Feb 11, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jan BorénMarja-Riitta Taskinen
Jan 20, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Gösta FlorvallAnders Larsson
Jan 5, 2006·Critical Reviews in Clinical Laboratory Sciences·Amanda J HooperJohn R Burnett
Mar 31, 2012·Expert Review of Cardiovascular Therapy·Adie Viljoen, Anthony S Wierzbicki
Jul 14, 2009·Metabolism: Clinical and Experimental·Seiko OtokozawaErnst J Schaefer
Jul 18, 2008·Diabetes Research and Clinical Practice·Kyoko TanimuraShinichi Oikawa
Nov 18, 2006·Clinics in Laboratory Medicine·Jeffrey S Cohn
Aug 29, 2006·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Kim G JacksonChristine M Williams
Jan 17, 2016·Journal of Lipid Research·Mikaël CroyalEstelle Nobécourt
Apr 26, 2007·European Journal of Clinical Nutrition·D LaironC Williams
May 22, 2007·Biochemical Society Transactions·R MangatS D Proctor

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.